Literature DB >> 25591451

Kindler syndrome protein Kindlin-1 is mainly expressed in adult tissues originating from ectoderm/endoderm.

Jun Zhan1, Mei Yang, Jing Zhang, YongQing Guo, Wei Liu, HongQuan Zhang.   

Abstract

Mutations of integrin-interacting protein Kindlin-1 cause Kindler syndrome and deregulation of Kindlin-1 is implicated in human cancers. The Kindlin-1-related diseases are confined in limited tissue types. However, Kindlin-1 tissue distribution and the dogma that governs Kindlin-1 expression in normal human body are elusive. This study examined Kindlin-1 expression in normal human adult organs, human and mouse embryonic organs by immunohistochemical analyses. We identified a general principle that the level of Kindlin-1 expression in tissues is tightly correlated with the corresponding germ layers from which these tissues originate. We compared the expression of Kindlin-1 with Kindlin-2 and found that Kindlin-1 is highly expressed in epithelial tissues derived from ectoderm and endoderm, whereas Kindlin-2 is mainly expressed in mesoderm-derived tissues. Likewise, Kindlin-1 was also found highly expressed in endoderm/ectoderm-derived tissues in human and mouse embryos. Our findings indicate that Kindlin-1 may play an importance role in the development of endoderm/ectoderm related tissues.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25591451     DOI: 10.1007/s11427-014-4775-2

Source DB:  PubMed          Journal:  Sci China Life Sci        ISSN: 1674-7305            Impact factor:   6.038


  2 in total

1.  Focal adhesion molecule Kindlin-1 mediates activation of TGF-β signaling by interacting with TGF-βRI, SARA and Smad3 in colorectal cancer cells.

Authors:  Jinfeng Kong; Juan Du; Yunling Wang; Mingzi Yang; Jianchao Gao; Xiaofan Wei; Weigang Fang; Jun Zhan; Hongquan Zhang
Journal:  Oncotarget       Date:  2016-11-15

2.  Therapeutic strategies against cancer stem cells in human colorectal cancer.

Authors:  Magdalena Szaryńska; Agata Olejniczak; Jarosław Kobiela; Piotr Spychalski; Zbigniew Kmieć
Journal:  Oncol Lett       Date:  2017-10-23       Impact factor: 2.967

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.